大师级运动员心血管异常临床共识:EAPC/ESC 与 ACC 联合声明
本共识针对大师级运动员这一特殊人群,系统梳理心房颤动、缓慢性心律失常、室性心律失常、冠状动脉粥样硬化、主动脉扩张、心肌纤维化及运动诱发的致心律失常性心肌病等异常。现有指南多基于有症状的久坐患者数据,对高强度训练人群适用性有限。共识提供基于专家的诊断评估、管理与预后路径,并指出未来需开展运动员随机对照试验和国际注册研究。
要点
- 大师级运动员房颤、冠脉粥样硬化、主动脉扩张和心肌纤维化患病率可能高于活动较少的同龄人。
- 现有指南多基于久坐患者数据,直接套用于高强度训练的运动员存在局限。
- 建议采集可穿戴设备心血管健康数据,并关注运动员症状表现与久坐人群的差异。
核心结论
- 大师级运动员可能出现房颤、冠脉粥样硬化、主动脉扩张和心肌纤维化等心血管异常,其患病率可能高于活动较少的同龄人。
研究设计与样本
- 本文件为欧洲预防心脏病学会/欧洲心脏病学会与美国心脏病学会联合发布的临床共识声明。
- 采用专家为基础的路径,对七类心血管异常的诊断评估、管理和预后提出建议。
主要发现
- 运动训练可改善心血管健康并降低未来心血管事件和死亡风险。
- 大师级运动员中心血管异常患病率可能较活动较少同龄人更高。
- 运动员症状表现与久坐人群不同,且可能对启动药物治疗存在抵触。
关键数值与推荐
- 涵盖房颤、缓慢性心律失常、室性心律失常、冠状动脉粥样硬化、主动脉扩张、心肌纤维化及运动诱发的致心律失常性心肌病。
- 建议纳入可穿戴设备提供的心血管健康相关数据用于临床评估。
临床怎么用
- 对运动员的心血管异常管理不宜直接照搬基于久坐患者制定的指南。
- 评估时需考虑运动员症状表现差异、治疗接受度及可穿戴设备数据。
局限性
- 现有指南多来源于有症状的久坐患者数据,对高强度训练人群适用性有限。
- 尚缺乏运动员中的临床结局研究和专门随机对照试验,也缺少多样人群的国际注册及纵向随访数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Exercise training improves cardiovascular health and reduces the risk for future cardiovascular events and mortality. However, emerging evidence suggests that Masters athletes may have a higher prevalence of cardiovascular abnormalities, such as atrial arrhythmias, coronary atherosclerosis, aortic dilatation, and myocardial fibrosis, compared to their less active peers. The clinical management of Masters athletes may be challenging as available guidelines for such conditions are generally based on data derived from symptomatic sedentary patients, limiting their applicability to highly trained individuals. Other unique challenges in the clinical assessment of Masters athletes include differences in symptomatic presentations compared to sedentary individuals, potential resistance to the initiation of pharmacologic treatment, and the increasing availability of consumer wearable health data that may provide relevant information on their cardiovascular health status. The purpose of this joint EAPC/ESC and ACC Clinical Consensus Statement is to provide an in-depth update on the current state of knowledge on abnormal cardiovascular findings in Masters athletes. We present an expert-based approach on the diagnostic assessment, management, and prognosis of (i) atrial fibrillation, (ii) bradyarrhythmias, (iii) ventricular arrhythmias, (iv) coronary atherosclerosis, (v) aortic dilatation, (vi) myocardial fibrosis, and (vii) exercise-induced arrhythmogenic cardiomyopathy. Clinical challenges, areas of ongoing controversy, and uncertainty and the potential underlying mechanisms are discussed. We also present future perspectives and research directives to further refine current best practice strategies. This includes the need for clinical outcome studies, dedicated randomized controlled trials in athletes, and international registries with diverse populations and longitudinal follow-up to evaluate the natural history of cardiac abnormalities and facilitate development of evidence-based approaches in the clinical management of Masters athletes with cardiovascular abnormalities.
引用
- Eijsvogels, Kim, Aengevaeren, et al. Masters Athletes With Abnormal Cardiovascular Findings: A Clinical Consensus Statement of the European Association of Preventive Cardiology of the ESC and the American College of Cardiology. J Am Coll Cardiol. 2026. PMID: 41941267. doi:10.1016/j.jacc.2026.03.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。